HomoCulture Logo - New

FDA Approves ONE and MyONE Condoms for Anal Sex

by | Feb 28, 2022

Are condoms redefining safety? Imagine a world where the very tool designed to protect sexual health finally receives recognition for its role in anal intercourse. In a groundbreaking revelation, the FDA has extended its approval to include ONE® Condoms for anal sex, marking a monumental shift in sexual health practices. Emory University’s rigorous study, led by Dr. Aaron Siegler, laid the foundation, demonstrating the efficacy of ONE® and myONE® Condoms with a remarkable failure rate of less than 1%. With this approval, a new era in sexual health dawns, promising greater confidence and protection for all.

The FDA’s Milestone Decision

Enter the FDA’s historic declaration, echoing the significance of condoms now tested and labeled specifically for anal intercourse. While reaffirming the suitability of all FDA-cleared condoms for contraception and STI prevention, this milestone authorization underscores the critical importance of tailored solutions for diverse sexual practices. Dr. Siegler’s comprehensive research, culminating in a less than 1% failure rate for ONE® and myONE® Condoms during anal sex, paved the way for this pivotal moment. The FDA’s acceptance of the De Novo Request on February 23rd, 2022, marks a paradigm shift, empowering individuals to embrace safer sexual practices confidently.

A Paradigm Shift in Contraception

Witness the dawn of a new era in sexual health as ONE® and myONE® Condoms secure FDA approval for anal sex—a long-awaited recognition of diverse sexual practices. Unveiled through Emory University’s groundbreaking study, these condoms boast a remarkable failure rate of just 0.68%, offering unparalleled protection and reassurance. As President of the brand rightly acknowledges, this landmark shift signifies a collaborative triumph of research, advocacy, and innovation in public health efforts. Dr. Siegler’s assertion further illuminates the gravity of this moment, emphasizing the vital role of FDA-approved condoms in curbing HIV transmission.

Embracing Confidence in Sexual Health

Step into a future where sexual health knows no bounds, as FDA-approved condoms pave the way for safer, more inclusive practices. With ONE® and myONE® Condoms leading the charge, individuals can embrace sexual confidence with unparalleled protection and peace of mind. Gone are the days of uncertainty; welcome to a world where condoms are tailored to meet the diverse needs of every individual, regardless of sexual orientation or preference. As this monumental shift unfolds, stay tuned for the latest updates shaping the landscape of sexual health and empowerment.

Sealing the Path to Safer Intimacy

Dive into the depths of safer intimacy, where ONE® Condoms emerge as a beacon of protection and reassurance for all. With FDA approval for anal sex, a new chapter unfolds, promising heightened confidence and security in every intimate encounter. As research continues to evolve, ONE® and myONE® Condoms stand at the forefront, championing inclusivity and efficacy in sexual health. Embrace the future of safer intimacy—where every encounter is fortified by the trust and reliability of FDA-approved protection.

Rate this post

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

ad-banner

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

ad-banner

Triston Brewer

Triston Brewer

Author

Join our newsletter

GDPR

Popular Categories

A group of gay men in front of a Sayulita sign.

Travel Guides

Make It Gay, Your Way, Visit Whitehorse in Canada’s Yukon Territory

Travel Tips

A man decked out in Pride accessories and a sequin shirt, marching in the 2023 Key West Pride Parade.

Celebrate Pride

Asia O’hara, Kameron Michaels, Kim Chi, and Aquaria Drag Queens (RuPaul Drag Race)

Friends of Homoculture

Join our newsletter

GDPR